Novo Holdings A/S - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$47,400,000
+8.8%
1,500,000
-10.9%
3.50%
+4.0%
Q2 2023$43,570,073
+7.7%
1,684,1930.0%3.37%
+26.2%
Q1 2023$40,454,316
+23.2%
1,684,1930.0%2.67%
+30.2%
Q4 2022$32,841,764
-7.2%
1,684,1930.0%2.05%
+21.5%
Q3 2022$35,385,000
-6.7%
1,684,193
-16.9%
1.69%
-9.7%
Q2 2022$37,931,000
-21.7%
2,027,324
-7.8%
1.87%
-26.9%
Q1 2022$48,444,000
+24.2%
2,200,000
-10.0%
2.56%
+38.3%
Q4 2021$39,000,000
-19.9%
2,445,1470.0%1.85%
-26.7%
Q3 2021$48,707,000
+15.2%
2,445,1470.0%2.52%
+34.3%
Q2 2021$42,277,000
-12.8%
2,445,1470.0%1.88%
-6.3%
Q1 2021$48,463,000
+13.5%
2,445,1470.0%2.00%
+9.3%
Q4 2020$42,692,000
-9.4%
2,445,1470.0%1.83%
-21.8%
Q3 2020$47,118,000
-1.0%
2,445,1470.0%2.34%
-23.9%
Q2 2020$47,583,000
+39.0%
2,445,1470.0%3.07%
+34.4%
Q1 2020$34,232,000
-42.9%
2,445,1470.0%2.28%
-40.8%
Q4 2019$59,955,000
+143.7%
2,445,1470.0%3.86%
-8.4%
Q3 2019$24,598,0002,445,1474.21%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders